Nanobac Pharmaceuticals Incorporated (NNBP)
OTHER OTC:NNBP
Holding NNBP?
Track your performance easily

Nanobac Pharmaceuticals (NNBP) Income Statement

5 Followers

Nanobac Pharmaceuticals Income Statement

Last quarter (Q ), Nanobac Pharmaceuticals's total revenue was $4.37K, an increase of 86.59% from the same quarter last year. In Q, Nanobac Pharmaceuticals's net income was $-1.17M. See Nanobac Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 07Dec 06Dec 05Dec 04Dec 03
Total Revenue
$ 17.62K$ 17.62K$ 225.09K$ 656.80K$ 358.36K$ 482.81K
Cost of Revenue
$ 14.52K$ 14.52K$ 79.81K$ 229.45K$ 100.47K$ 333.12K
Gross Profit
$ 3.10K$ 3.10K$ 145.28K$ 427.36K$ 257.89K$ 149.69K
Operating Expense
$ 3.56M$ 4.92M$ 4.96M$ 3.27M$ 7.86M$ 2.85M
Operating Income
$ -3.56M$ -4.91M$ -4.81M$ -2.84M$ -7.60M$ -2.70M
Net Non Operating Interest Income Expense
------
Other Income Expense
$ -1.47M$ -1.47M$ -544.82K$ -778.76K$ 30.93K$ -21.53K
Pretax Income
$ -6.58M$ -6.58M$ -4.97M$ -3.69M$ -7.82M$ -2.76M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -6.58M$ -6.58M$ -4.97M$ -3.69M$ -7.87M$ -3.70M
Basic EPS
$ -0.03$ -0.03$ -0.02$ -0.02$ -0.05$ -0.05
Diluted EPS
$ -0.03$ -0.03$ -0.02$ -0.02$ -0.05$ -0.05
Basic Average Shares
$ 978.49M$ 245.20M$ 199.43M$ 188.86M$ 152.90M$ 67.49M
Diluted Average Shares
$ 978.49M$ 245.20M$ 247.48M$ 189.01M$ 185.86M$ 67.49M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 3.57M$ 4.93M$ 5.04M$ 3.49M$ 7.96M$ 3.18M
Net Income From Continuing And Discontinued Operation
$ -6.58M$ -6.58M$ -4.97M$ -3.69M$ -7.87M$ -3.70M
Normalized Income
$ -5.10M$ -5.10M$ -4.43M$ -2.91M$ -7.85M$ -2.74M
Interest Expense
------
EBIT
$ -3.56M$ -4.91M$ -4.81M$ -2.84M$ -7.60M$ -2.70M
EBITDA
$ -3.10M$ -4.45M$ -4.27M$ -2.08M$ -6.88M$ -2.52M
Currency in USD

Nanobac Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis